Ethos Technologies Inc. (LIFE) Earnings Call Transcripts
Ethos Technologies Inc.'s Latest Earnings Call - Q1 FY2026
In Q1 2026, Lifecare ASA reported revenue of NOK 7.08 million, primarily from government grants, marking a significant operational transition as the company moves towards a more scalable manufacturing model. The quarter was characterized by key milestones, including achieving CE mark for implant electronics and demonstrating stable implant performance beyond 12 weeks. Management has signaled a shift in strategy, simplifying the regulatory pathway and focusing on cost reductions, with expectations of a 35% decrease in employee expenses going forward. The company has also recognized a NOK 12 million impairment loss related to the wind-down of its German operations, which will not impact cash flow.
Reported metrics
| Metric | Value |
|---|---|
| Revenue | NOK 7.08 million (miss) |
| Impairment Loss | NOK 12 million (negative) |
| Employee Benefit Expenses | NOK 8.5 million (positive) |
| Other Operating Expenses | NOK 9.5 million (positive) |
| Cash Position | NOK 26 million (positive) |
| Cost Reduction Expectation | 35% (positive) |
Guidance from management
Management expects to provide a more detailed roadmap regarding regulatory strategy and operational execution by the next quarterly report in August 2026. They anticipate significant cost reductions and improved operational efficiency as they transition to the Bergen facility.
What analysts pressed on
Analysts expressed concerns regarding the timeline for regulatory approvals and the impact of the German operations wind-down on future performance. There were questions about the company's ability to generate revenue from the veterinary market in the near term, with management indicating that significant revenues are not expected in H2 2026.
Main topics on the call
- Regulatory Milestones — Lifecare achieved significant regulatory milestones, including the CE mark for implant electronics, which is crucial for commercial sales in Europe. Management stated, "This is an important validation of the regulatory q...
- Operational Transition — The company is transitioning to a more centralized manufacturing model in Bergen, which is expected to enhance operational control and scalability. Management emphasized, "We are moving towards a leaner and more scalable...
- Cost Reduction Strategy — Management expects to reduce employee benefit expenses by approximately 35% due to the operational restructuring. The CFO noted, "We are lowering our cost base," indicating a focus on improving financial efficiency.
- Impairment Loss — The company recognized a NOK 12 million impairment loss related to the wind-down of its German operations, which was highlighted as a non-cash effect. The CFO clarified, "These effects do not have a cash flow element."
Read the full Ethos Technologies Inc. transcript (Q1 FY2026) → Summary generated from the call transcript; every figure above is stated by management on the record.
About Ethos Technologies Inc.
Ethos Technologies Inc. (LIFE) is a publicly listed company in the Insurance industry, within the Financials sector. It trades on NasdaqGS and is based in US. EarningsCalls.dev maintains a free, full-text archive of its earnings call transcripts — 7 calls on record spanning February 20, 2025 to August 3, 2026. Every transcript is split into speaker-by-speaker segments with headline metrics, free to read or available through our REST API.
Earnings Call History
EarningsCalls.dev has 7 Ethos Technologies Inc. earnings call transcripts on record, spanning February 20, 2025 to August 3, 2026. Based on this history, Ethos Technologies Inc. reports quarterly. The most recent call on file is dated August 3, 2026. The full list is below — each row opens the complete, free-to-read transcript.
- Ticker
- LIFE
- Exchange
- NasdaqGS
- Country
- US
- Sector
- Financials
- Industry
- Insurance
- Calls on record
- 7
- First call
- February 20, 2025
- Most recent
- August 3, 2026
- Reporting cadence
- quarterly
| Quarter | Date | |
|---|---|---|
| Q2 FY2026 | Aug 3, 2026 | Read transcript → |
| Q1 FY2026 | May 15, 2026 | Read transcript → |
| Q1 FY2026 | May 6, 2026 | Read transcript → |
| Q4 FY2025 | Mar 3, 2026 | Read transcript → |
| Q3 FY2026 | Feb 25, 2026 | Read transcript → |
| Q1 FY2025 | May 15, 2025 | Read transcript → |
| Q4 FY2024 | Feb 20, 2025 | Read transcript → |